Cetuximab pharmacokinetics and its influence on survival in a cohort of head and neck squamous cell carcinoma (HNSCC).
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 19 Dec 2017 New trial record